招聘
Benefits & Perks
•Healthcare
•401(k)
•Equity
•Unlimited PTO
•Gym
•Parental Leave
•Learning Budget
•Healthcare
•401k
•Equity
•Unlimited Pto
•Gym
•Parental Leave
•Learning
Required Skills
Scientific expertise
Neuromuscular biology
Leadership
Team management
Strategic planning
Scientific communication
External partnerships
Innovation management
About This Role
This is an outstanding opportunity to join a dynamic neurology team as the Head of Neuromuscular Research. Reporting to the Head of Neurology Research, you will be responsible for defining and leading the research strategy across established and emerging neuromuscular disease areas. This includes supporting our established franchises in spinal muscular atrophy and amyotrophic lateral sclerosis.
A key objective will be to maintain strong momentum in existing research programs, while strategically integrating external innovation to enrich and sustain a high-value discovery pipeline. In this pivotal leadership role, you will collaborate across Biogen’s global organization and external stakeholders to ensure alignment with enterprise priorities and deliver impactful outcomes. You will also take leadership of a highly talented and engaged team of scientists, fostering a culture of excellence and innovation.
What You’ll Do
-
Inspire, develop, and lead a team of talented and committed scientists. Foster a high-performing, collaborative culture that values creativity, scientific rigor, and operational excellence.
-
Define and execute a strong, forward-thinking, and cross-functionally aligned neuromuscular research strategy, ensuring alignment with Biogen’s broader neurology research vision and organizational goals.
-
Deliver a high value neuromuscular research programs into clinical studies, prioritizing resources to address unmet medical needs and accelerate the advancement of differentiated therapies.
-
Drive integration of promising innovation into a sustainable neuromuscular discovery pipeline through research efforts and external partnerships, leveraging cutting-edge technologies and scientific advances.
-
Act as a strategic stakeholder, collaborating with cross-functional leaders, for the neuromuscular franchise.
-
Contribute to the leadership of a world class neurology team and pipeline, contributing to overall organizational strategy and decision-making.
-
Represent Biogen as a thought leader in neuromuscular research, engaging with external collaborators, and academic institutions, and industry partners to advance innovation and establish Biogen as a thought global leader in neuromuscular disease research.
Who You Are
You are a dynamic, visionary, and agile leader with a proven track record of driving innovation and delivering transformative solutions in neuromuscular research. You are an inspiring communicator who thrives at the intersection of science and strategy, and you excel at building relationships, aligning teams, and making data-driven decisions. You are committed to the pursuit of innovative science to deliver breakthrough medicines, whilst fostering a culture of excellence and resilience within your team.
Required Skills:
-
Strong scientific expertise and background. PhD in neuroscience or neuromuscular biology, or related life sciences field with 15+ years of experience.
-
Proven track record of leading scientific teams (minimum of 5+ years), with demonstrated ability to attract, develop, and retain top tier talent.
-
Deep experience in biopharma environment/industry (minimum of 10+ years).
-
Open and direct communication style/demonstrable speaker experience and thought leader at both internal and external forums.
-
Experience establishing and managing external collaborations and partnerships, including licensing and innovation initiatives.
Job Level: Management
Additional Information:
The base compensation range for this role is: $246,000.00-$338,000.00
Base salary offered is determined through an analytical approach utilizing a combination of factors including, but not limited to, relevant skills & experience, job location, and internal equity.
Regular employees are eligible to receive both short term and long-term incentives, including cash bonus and equity incentive opportunities, designed to reward recent achievements and recognize your future potential based on individual, business unit and company performance.
In addition to compensation, Biogen offers a full and highly competitive range of benefits designed to support our employees’ and their families physical, financial, emotional, and social well-being; including, but not limited to:
- Medical, Dental, Vision, & Life insurances
- Fitness & Wellness programs including a fitness reimbursement
- Short- and Long-Term Disability insurance
- A minimum of 15 days of paid vacation and an additional end-of-year shutdown time off (Dec 26-Dec 31)
- Up to 12 company paid holidays + 3 paid days off for Personal Significance
- 80 hours of sick time per calendar year
- Paid Maternity and Parental Leave benefit
- 401(k) program participation with company matched contributions
- Employee stock purchase plan
- Tuition reimbursement of up to $10,000 per calendar year
- Employee Resource Groups participation
Why Biogen?
We are a global team with a commitment to excellence, and a pioneering spirit. As a mid-sized biotechnology company, we provide the stability and resources of a well-established business while fostering an environment where individual contributions make a significant impact. Our team encompasses some of the most talented and passionate achievers who have unparalleled opportunities for learning, growth, and expanding their skills. Above all, we work together to deliver life-changing medicines, with every role playing a vital part in our mission. Caring Deeply. Achieving Excellence. Changing Lives.
At Biogen, we are committed to building on our culture of inclusion and belonging that reflects the communities where we operate and the patients we serve. We know that diverse backgrounds, cultures, and perspectives make us a stronger and more innovative company, and we are focused on building teams where every employee feels empowered and inspired. Read on to learn more about our DE&I efforts.
All qualified applicants will receive consideration for employment without regard to sex, gender identity or expression, sexual orientation, marital status, race, color, national origin, ancestry, ethnicity, religion, age, veteran status, disability, genetic information or any other basis protected by federal, state or local law. Biogen is an E-Verify Employer in the United States.
Total Views
0
Apply Clicks
0
Mock Applicants
0
Scraps
0
Similar Jobs

Director, Research Systems
Gilead Sciences · United States - California - Foster City

Team Lead Research & Insight (m/w/d)
Cushman & Wakefield · CW Site - DEU - Frankfurt - Bleidenstrasse 6

Director, Clinical Scientist, Hematology
Regeneron · 2 Locations

Lead Scientist - Artificial Intelligence
GE Vernova · Niskayuna

Associate Director, Clinical Scientist, Oncology
Regeneron · 2 Locations
About Biogen

Biogen
PublicSpecializing in the treatment of neurological diseases.
5,001-10,000
Employees
Cambridge
Headquarters
Reviews
4.1
47 reviews
Work Life Balance
3.6
Compensation
4.7
Culture
4.1
Career
4.4
Management
3.8
84%
Recommend to a Friend
Pros
Opportunities for continuous learning and growth
Strong engineering culture with focus on code quality
Cutting-edge technology stack and interesting technical challenges
Cons
Organizational changes and restructuring can be disruptive
Fast-paced environment with tight deadlines
Work-life balance can be challenging during product launches
Salary Ranges
541 data points
Mid/L4
Senior/L5
Mid/L4 · SR Analyst, R&D Business Ops
1 reports
$131,388
total / year
Base
$114,250
Stock
-
Bonus
-
$131,388
$131,388
Interview Experience
47 interviews
Difficulty
3.5
/ 5
Duration
14-28 weeks
Offer Rate
36%
Experience
Positive 65%
Neutral 25%
Negative 10%
Interview Process
1
Phone Screen
2
Technical Interview
3
System Design
4
Behavioral
5
Team Fit
Common Questions
Tell me about a challenging project
System design question
Coding problem
Why this company
News & Buzz
FDA grants breakthrough therapy designation to Biogen’s litifilimab - Investing.com
Source: Investing.com
News
·
5w ago
Biogen’s Litifilimab Receives FDA Breakthrough Therapy Designation for Cutaneous Lupus Erythematosus, a Disease With No Targeted Treatment Options - Biogen
Source: Biogen
News
·
5w ago
FDA Accepts LEQEMBI® IQLIK™ (lecanemab-irmb) Supplemental Biologics License Application as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer’s Disease under Priority Review - Biogen
Source: Biogen
News
·
5w ago
Biogen’s Alisha Alaimo On The Company’s Next Big Commercial Build - Citeline News & Insights
Source: Citeline News & Insights
News
·
6w ago